Published in Biotech Business Week, February 24th, 2003
Haemacure also obtained the right of first refusal on the distribution of these products in certain other countries. This agreement will soon yield benefits as Haemacure already serves over a thousand hospitals where these types of products are currently used.
"This agreement enables us to broaden our product lines and build upon our current distribution structure," said Marc Paquin,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.